Background Thirteen COVID-19 vaccines are granted emergency approval. It is crucial to
monitor their adverse events post vaccination. The present study focuses on cardiovascular …

Given the urgent need to control the spread of the novel COVID-19 virus, 13 vaccines have
been approved for emergency use before completing all 3 phases of the clinical trials …

Coronavirus disease 2019 (COVID-19) has become a global public health catastrophe.
Vaccination against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is …

COVID-19 vaccination related adverse events is an evolving field. Here we present a case of
acute myocardial injury that developed as a result of an acute immune response following …

Background There are multiple reviews on cardiovascular aspects of COVID-19 disease on
cardiovascular system in different population but there is lack of evidence about …

Since COVID‐19 took a strong hold around the globe causing considerable morbidity and
mortality, a lot of effort was dedicated to manufacturing effective vaccines against SARS …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the deadly
disease known as coronavirus disease 2019 (COVID-19) that has reached pandemic …

The COVID-19 pandemic had a severe global impact. A range of campaigns and activities,
including vaccines, are being implemented to counteract this pandemic. Using observational …

Background Rapid deployment of COVID-19 vaccines is challenging for safety surveillance,
especially on adverse events of special interest (AESIs) that were not identified during the …

Abstract Background The Pfizer BioNTech COVID-19 vaccine was the first to receive
emergency authorization and approval from the FDA. Therefore, it is preferred by most …